Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in cases of chronic hepatitis B

Journal of Clinical Microbiology

Volumn 41, Issue 10, 2003, Pages 4793-4795

  Chan, Henry Lik Yuen ^a,b   Wong, May Ling ^a   Hui, Alex Yui ^a   Hung, Lawrence Cheung Tsui ^a   Chan, Francis Ka Leung ^a   Sung, Joseph Jao Yiu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CHILD; DNA, VIRAL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; VIRAL LOAD;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0141889181     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.10.4793-4795.2003     Document Type: Article

References (18)

1. Chan, H. L. Y., Y. Hui, N. W. Y. Leung, J. Y. L. Ching, F. K. L. Chan, and J. J. Y. Sung. 2000. Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus (HBV) infected patients. Am. J. Gastroenterol. 95:3547-3551.
2. Chan, H. L. Y., N. W. Y. Leung, M. Hussain, M. L. Wong, and A. S. F. Lok. 2000. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 31:763-768.
3. Chan, H. L. Y., S. W. C. Tsang, C. T. Liew, C. H. Tse, M. L. Wong, J. Y. L. Ching, N. W. Y. Leung, J. S. L. Tam, and J. J. Y. Sung. 2002. Viral genotype and hepatitis B virus DNA levels are correlated with histologic liver damage in HBeAg-negative chronic hepatitis B virus infection. Am. J. Gastroenterol. 97:406-412.
4. Chan H. L. Y., A. K. K. Chui, W. Y. Lau, F. K. L. Chan, M. L. Wong, C. H. Tse, A. R. N. Rao, J. Wong, and J. J. Y. Sung. 2002. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. J. Med. Virol. 68:182-187.
5. Chan, H. L. Y., M. L. Wong, A. Y. Hui, L. C. T. Hung, F. K. L. Chan, and J. J. Y. Sung. 2003. Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis. B virus genotype B in hepatitis B e antigen-positive patients. J. Clin. Microbiol. 41:1277-1279.
6. Chu, C. J., M. Hussain, and A. S. F. Lok. 2002. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 36:1408-1415.
7. Di Marco, V., O. L. Iacono, C. Camma, A. Vaccaro, M. Giunta, G. Martorana, P. Fuschi, P. Almasio, and A. Craxi. 1999. The long-term course of chronic hepatitis B. Hepatology 30:157-164.
8. Hsu, Y. S., R. N. Chien, C. T. Yeh, I. S. Sheen, H. Y. Chiou, C. M. Chu, and Y. F. Liaw. 2002. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35:1522-1527.
9. Lindh, M., A. S. Andersson, and A. Gusdal. 1997. Genotypes, nt 1858 variants, and geographical origin of hepatitis B virus-large-scaled analysis using a new genotyping method. J. Infect. Dis. 175:1285-1293.
10. Lindh, M., P. Horal, A. P. Dhillon, and G. Norkrans. 2000. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J. Viral Hepat. 7:258-267.
11. Loeb, K. R., K. R. Jerome, J. Goddard, M. L. Huang, A. Cent, and L. Corey. 2000. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32:626-629.
12. Lok, A. S. F., C. L. Lai, P. C. Wu, E. K. Y. Leung, and T. S. Lam. 1987. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 92:1839-1843.
13. Lok, A. S. F., E. J. Heathcote, and J. H. Hoofnagle. 2001. Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology 120:1828-1853.
14. Manesis, E. L., G. V. Papatheodoridis, and S. J. Hadziyannis. 2002. Serum HBV-DNA levels in inactive hepatitis B virus carriers. Gastroenterology 122:2092-2093.
15. Martinot-Peignoux, M., N. Boyer, M. Colombat, R. Akremi, B. N. Pham, S. Ollivier, C. Castelnau, D. Valla, C. Degott, and P. Marcellin. 2002. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J. Hepatol. 36:543-546.
16. McMahon, B. J., P. Holck, L. Bulkow, and M. Smowball. 2001. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann. Intern. Med. 135:759-768.
17. Sung, J. J. Y., H. L. Y. Chan, M. L. Wong, C. H. Tse, S. C. H. Yuen, J. S. L. Tam, and N. W. Y. Leung. 2002. Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients. J. Viral Hepat. 9:229-234.
18. ter Borg, F., F. J. W. ten Kate, H. T. M. Cuypers, A. Leentvaar-Kuijpers, J. Oosting, P. M. E. Wertheim-van Dillen, P. Honkoop, M. C. Rasch, R. A. de Man, J. van Hattum, R. A. F. M. Chamuleau, H. W. Reesink, and E. A. Jones. 1998. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 351:1914-1918.